Why Immunome Stock Skyrocketed Today

Shares of Immunome (NASDAQ:IMNM) soared on Thursday after the biotech announced the discovery of antibodies that could neutralize multiple coronavirus variants. 

By the close of trading, Immunome's stock price was up 75% after rising as much as 187% earlier in the day.

Immunome said it isolated "potent" antibodies that are potentially capable of neutralizing several variants of SARS-CoV-2, the virus that causes COVID-19. These strains include the South African variant, according to the company.

Continue reading

Source Fool.com